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Abstract
Protein-protein interaction networks provide a global picture of cellular function and biological processes. Some proteins
act as hub proteins, highly connected to others, whereas some others have few interactions. The dysfunction of some
interactions causes many diseases, including cancer. Proteins interact through their interfaces. Therefore, studying the
interface properties of cancer-related proteins will help explain their role in the interaction networks. Similar or overlapping
binding sites should be used repeatedly in single interface hub proteins, making them promiscuous. Alternatively, multi-
interface hub proteins make use of several distinct binding sites to bind to different partners. We propose a methodology to
integrate protein interfaces into cancer interaction networks (ciSPIN, cancer structural protein interface network). The
interactions in the human protein interaction network are replaced by interfaces, coming from either known or predicted
complexes. We provide a detailed analysis of cancer related human protein-protein interfaces and the topological
properties of the cancer network. The results reveal that cancer-related proteins have smaller, more planar, more charged
and less hydrophobic binding sites than non-cancer proteins, which may indicate low affinity and high specificity of the
cancer-related interactions. We also classified the genes in ciSPIN according to phenotypes. Within phenotypes, for breast
cancer, colorectal cancer and leukemia, interface properties were found to be discriminating from non-cancer interfaces
with an accuracy of 71%, 67%, 61%, respectively. In addition, cancer-related proteins tend to interact with their partners
through distinct interfaces, corresponding mostly to multi-interface hubs, which comprise 56% of cancer-related proteins,
and constituting the nodes with higher essentiality in the network (76%). We illustrate the interface related affinity
properties of two cancer-related hub proteins: Erbb3, a multi interface, and Raf1, a single interface hub. The results reveal
that affinity of interactions of the multi-interface hub tends to be higher than that of the single-interface hub. These findings
might be important in obtaining new targets in cancer as well as finding the details of specific binding regions of putative
cancer drug candidates.
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Introduction
Protein–protein interaction networks provide valuable informa-
tion in the understanding of cellular function and biological
processes. With the tremendous increase in human protein
interaction data, network approach is used to understand
molecular mechanisms of disease [1] particularly to analyze
cancer phenomenon. To date, attempts at providing insights into
distinct topological features of cancer genes [2–5] have illustrated
how to improve cancer classification [6,7] and identified cancer-
related subnetworks [8]. Thus, abstract network representation,
where proteins are nodes and interactions are edges, is useful for
the comprehension of biological processes and protein function in
a global sense. However, to characterize interactions with respect
to their physical and chemical properties and in particular, to
understand how a function is exerted, it is essential to include
structural details in the networks; such details come from three
dimensional protein structures and from protein interfaces.
Proteins interact with each other through binding sites [9–13].
Interface characteristics are important in determining the
specificity and strength of interactions. For example, conserved
modes are used to distinguish biological from crystal interactions
[14]. Different in residue composition, transient and obligate
complexes have different strength of interactions; the former
mostly rely on salt bridges and hydrogen bonds whereas for the
latter, hydrophobic forces are more dominant [15,16]. In terms of
geometrical concern, if two proteins interact through a large
interface with high complementarity, they will probably interact
with high specificity and high affinity [17]. Physical interactions
through interface residues also determine whether the binding will
be promiscuous or specific.
Structural knowledge of proteins is also critical in identifying
whether a binding site is specific or multiply used. Since each
protein has almost a fixed surface area, it can have a limited
number of binding sites. How can a hub protein interact with tens
of other proteins through its binding sites? This question implies
that whereas some binding sites are distinct, others should be used
to bind to several different proteins. Therefore, the same or
overlapping binding sites should be frequently and repeatedly used
in hub proteins making them promiscuous [18]. With this in mind,
Kim et al. [19] distinguished overlapping from non-overlapping
interfaces in their structural interaction network to determine
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interface and multi-interface. The former have at most two distinct
binding interfaces and the interactions exclude each other whereas
the latter have more than two binding interfaces with most of the
interactions being possible simultaneously.
Knowing that cancer-related proteins are more likely to act as
hubs [2] in protein interaction networks, the questions that arise
are what features of cancer-related proteins make them act as hubs
and how is it possible for them to bind to many different proteins
with varying affinity. To address these questions, as distinct from
previous structural studies [19–25], here we integrate protein-
protein interfaces into a structural network, focus on cancer-
related proteins and investigate the interface properties of cancer/
noncancer protein interactions in order to shed light on the details
of interaction. We provide a detailed analysis and comparison of
six interaction networks: 1) the human protein-protein interaction
network, (PIN), 2) the human cancer-related protein-protein
interaction network, cPIN, a sub-network of the first. Then, we
characterize the interactions in these networks by combining
three-dimensional protein structures. Thus, we have: 3) the
network constructed by selecting genes for which three-dimen-
sional protein data is available, SPIN, a sub-network of the first, 4)
the human cancer-related structural protein-protein interaction
network, cSPIN, a sub-network of SPIN. We map the known
structural data into these networks whenever a complex structure
is available. For the rest, we predict the complex structures of the
interactions through structural templates and hot spots using
PRISM [26,27]. The last two resulting networks are ‘‘structural
interface’’ networks: 5) human structural protein interface network
(iSPIN) and 6) structural cancer-related protein interface network
(ciSPIN). These six networks are analyzed and compared to
highlight the advantages of using structures. Our results reveal that
cancer-related proteins tend to interact with their partners through
distinct interfaces, corresponding mostly to multi-interface hubs
and constituting the nodes with higher essentiality in the network.
In addition, they have smaller, more planar and more hydrophilic
binding sites compared to those seen in non-cancer proteins which
may indicate low affinity and high specificity of the cancer-related
interactions.
Results/Discussion
Structural protein interface network (iSPIN)
We illustrate how to obtain a structure-integrated network from
PIN: The seed network is the human protein-protein interaction
network (PIN) where the nodes are proteins and the edges are
interactions. We determined which proteins in this network have
structural information in Protein Data Bank (PDB) [28] and
constructed a subnetwork with the extracted structures called
SPIN (see Methods for the details). To further integrate protein
interfaces into SPIN, we mapped the known structural data of
complexes into SPIN whenever a complex structure was available.
If a known structure was not available for an interaction, we
predicted the complex structures of the two interacting proteins
using structural templates and hot spots through PRISM [26,27].
The resulting network, which includes known complexes in PDB
and predicted complexes (from PRISM) contains interface
knowledge and is called iSPIN. The subsets of PIN, SPIN and
iSPIN, which contain cancer-related interactions, are called cPIN,
cSPIN and ciSPIN, respectively (See Methods section for further
information). Table 1 lists the number of proteins and interactions
in each network. In Table 1, ‘‘known complex in PDB’’ column
represents the number of interactions for which three dimensional
protein structures are available in PDB. The three networks (PIN,
SPIN, iSPIN) are illustrated in Figure 1.We should note that there
was a dramatic decrease in the number of proteins when going
from PIN to SPIN. As seen in Figure 1, while PIN contains
information about gene interactions, SPIN only contains those
with PDB IDs. And finally iSPIN contains the information at the
residue level; protein interfaces. Although we provide a topological
analysis of the networks, the main concern of this study is to
present interface analysis of cancer-related proteins and, in
addition, to predict which interactions can and cannot occur
simultaneously and ultimately, to emphasize the importance of
using structures in network studies.
Analysis of interface properties in iSPIN
We present the interface properties of interactions such as the
accessible surface area (ASA), planarity, gap volume index (see
definitions below) and residue composition at the interfaces in
iSPIN (both predicted and known PDB interfaces). To analyze the
properties of interfaces, we used PROTORP [29] (see Methods).
First, the analysis of the interface properties throughout the whole
network (iSPIN) is presented. Next, the analysis is restricted to
Author Summary
Protein-protein interaction networks provide a global
picture of cellular function and biological processes. The
dysfunction of some interactions causes many diseases,
including cancer. Proteins interact through their interfac-
es. Therefore, studying the interface properties of cancer-
related proteins will help explain their role in the
interaction networks. The structural details of interfaces
are immensely useful in efforts to answer some funda-
mental questions such as: (i) what features of cancer-
related protein interfaces make them act as hubs; (ii) how
hub protein interfaces can interact with tens of other
proteins with varying affinities; and (iii) which interactions
can occur simultaneously and which are mutually
exclusive. Addressing these questions, we propose a
method to characterize interactions in a human protein-
protein interaction network using three-dimensional
protein structures and interfaces. Protein interface anal-
ysis shows that the strength and specificity of the
interactions of hub proteins and cancer proteins are
different than the interactions of non-hub and non-cancer
proteins, respectively. In addition, distinguishing overlap-
ping from non-overlapping interfaces, we illustrate how a
fourth dimension, that of the sequence of processes, is
integrated into the network with case studies. We believe
that such an approach should be useful in structural
systems biology.
Table 1. The number of proteins and interactions in each
network.
Network name Protein Interaction Known complex in PDB
PIN 13584 85083 206
cPIN 8990 27413 149
SPIN 1702 5312 206
cSPIN 1303 3221 149
iSPIN 534 549 206
ciSPIN 381 363 149
doi:10.1371/journal.pcbi.1000601.t001
Structural Cancer Protein Interaction Network
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biological process.
Cancer proteins have smaller, more planar, less tightly
packed and less hydrophobic binding sites compared to
non-cancer proteins
Physical properties of interfaces were computed for the
interactions in iSPIN. We classified the interactions into two
groups: ‘‘cancer-related interactions’’ are those in which at least
one partner in a binary interaction is a cancer-related protein and
‘‘noncancer interactions’’ are those in which none of the proteins
are known to be involved in cancer. According to these
designations, there were 363 cancer-related and 186 non-cancer
interactions. Change in ASA (DASA) is the difference between the
total ASA of monomers and that of the complex. Cancer proteins
on average were observed to have smaller DASAs (1009.1 A ˚ 2) than
that of noncancer proteins (1242.9 A ˚ 2) (standard deviations and p-
values are summarized in Table 2). Next, we calculated the
interface ASA as the sum of ASAs of each interface residue in the
complex state. When the interface ASA of the complex structures
is considered, it was found that ASA of cancer proteins (2210.9 A ˚ 2)
were smaller than that of noncancer proteins (2628.1 A ˚ 2). These
results indicate that the complex interfaces which are formed
through the interactions of cancer proteins are less buried, or
likewise, the monomeric surfaces of cancer proteins are less
Figure 1. Representation of PIN,SPIN and iSPIN. In A) proteins in PIN are represented; the ones colored black have PDB IDs and the ones
colored blue do not have PDB IDs. In B) The proteins with PDB ID and interactions among them constitutes SPIN. In C) The proteins with PDB ID and
protein interface information and their interactions constitutes iSPIN. The zoomed representations give idea about what type of information each
network contains; PIN is an abstract representation of interactions, SPIN is a subset of PIN with information of PDB IDs, and iSPIN contains the most
detailed information including protein interfaces into network. All the networks are visualized using Cytoscape [76].
doi:10.1371/journal.pcbi.1000601.g001
Table 2. Average interface properties of cancer and non-cancer interactions. 6 in brackets refers to standard deviation.
Interface property Cancer-related interactions Non-cancer interactions p-value (at a=0.05)
DASA (A ˚2) 1009.1(6611) 1242.9(6942) 6.2e-005
Interface ASA (A ˚2) 2210.9 (61475) 2628.1(61947) 0.0006
Planarity (A ˚) 2.84(61.28) 3.06(61.23) 0.04
Gap Volume Index 2.76(61.48) 2.54(61.27) Not significant (0.07)
% Polar residues in interface 29.7 (614.8) 30.7 (613.5) Not significant (0.14)
% Non-polar residues in interface 27.1 (613.6) 28.8 (612.9) 0.007
% Charged residues in interface 43.2 (616.6) 40.5 (615.4) 0.006
doi:10.1371/journal.pcbi.1000601.t002
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interface areas [30]. Our results show that cancer proteins use a
smaller surface area while interacting and we know that they have
many interaction partners [3], thus it may be hypothesized that
they are more likely to be involved in transient interactions. Here,
we should note that although standard deviations of the two
datasets are high in all cases, i.e. the distributions of the data sets
are highly disperse, p-values at 5% confidence interval are small
indicating the significance of the difference between two means of
cancer-related and noncancer interfaces.
We also investigated the complementarity of the interfaces. Gap
volume provides a measure of complementarity and closeness of
packing of the interface between the two interacting proteins by
measuring the volume of empty space between them. Gap volume
index is the ratio of gap volume to the interface area; it estimates
the volume enclosed between any two molecules, delimiting the
boundary by defining a maximum allowed distance from both
interfaces [17]. For the cancer related interactions, the average
gap volume (5076.8 A ˚ 3) was found to be smaller than the average
gap volume of noncancer interactions (5574.5 A ˚ 3) (p-value=0.038
at a=0.05). This is an outcome of the smaller interfaces of the
cancer proteins since volume is proportional to the surface area.
On the other hand, the average gap volume indices for these two
categories were 2.76Au and 2.54 Au, respectively (p-value=0.07 at
a=0.05). This means cancer related interactions are less
optimized in terms of complementarity indicating that, the
complementarity and packing of two types (cancer/noncancer)
are distinguishable from each other.
Planarity indices are used to analyze the shapes of the interfaces.
The planarity of the interface is defined as the rmsd of the interface
atoms from the least-squares plane fitted through all interface
atoms. The larger the planarity index, the less planar the interface,
and, conversely, the smallerthe planarityindex,themore planarthe
interface [9]. For cancer-related interactions, the average planarity
index (2.84) was smaller than that of non-cancer interactions (3.06)
with p-value 0.04 indicating that cancer-related interfaces are more
planar. It is known that there is a high correlation between the
planarity of the interfaces and their ASAs [18]. As the ASAs of the
interfaces increase, the planarity index also increases, and the
interfaces become less planar, deviating from their principal axes. It
is also known that transient complexes usually have more planar
interfaces [30]. Here, consistent with previous findings, we observed
that cancer proteins use more planar binding sites in their
complexes. The results are summarized in Table 2.
Previously, smaller interfaces were shown to display a reduced
hydrophobic effect [31]. Residue compositions of interfaces (polar,
non-polar or charged) were analyzed in iSPIN and were
normalized by the ASA in the complex structures (see Methods).
The results revealed that cancer-related interactions show a
reduction in hydrophobicity and an increase in charged
interactions, and thus have more hydrophilic interfaces than
non-cancer interactions. Although, in general, it is agreed that
protein-protein interfaces are highly hydrophobic and hydropho-
bicity is a dominant force in protein-protein interactions [32],
there are also studies indicating the importance of hydrophilic
interface regions. Tormo et al. (1999) studied the interactions of
NK (natural killer) receptors (which regulates NK cell function)
and determined the interface of C-type-lectin-like receptor family
(Ly49 A) to be highly hydrophilic and dominated by charged
interactions [33]. Charged interactions appear to play important
role in our iSPIN interfaces as well, which implies that
electrostatics are significant in binding. A recent study indicated
that favorable electrostatic interactions were not a prerequisite for
stable complex formation between proteins whereas hydrophobic
effects were found to be favorable in native complexes [34]. Here,
we also observed that cancer related proteins, which are
intrinsically more disordered and transient [35], had less
hydrophobic interactions than other proteins.
Hub proteins have smaller, more planar, less tightly
packed binding sites than non-hub proteins
We also classified interactions as ‘‘hub-involved’’ or ‘‘non-hub-
involved’’. In hub-involved interactions, at least one protein of the
binary interaction is a hub protein, whereas in non-hub-involved
interactions, none of the proteins correspond to a hub. There were
455 hub-involved interactions and 94 non-hub-involved interactions.
AshubproteinsiniSPIN,weconsideredthehubsofSPIN.Wefound
that, on average, hub proteins tended to form smaller, more planar
interfaces with their partners. In contrast to previous studies [36,37],
we found no significant difference in the residue composition of the
interfaces (including charged residue content) of hub proteins. In
terms of complementarity of the interfaces, hub proteins formed
looser complexes (gap volume index of 2.72 versus 2.49). The results
are summarized in Table 3. (See first lines in each row)
Some hubs are single-interface (communicating with their
partners by using the same interface) whereas others are multi-
interface. The hub proteins of SPIN with more than two
interactions in iSPIN were classified as either multi-interface or
single-interface hubs resulting in 79 hub proteins, of which 42 were
multi-interface and 37 were single-interface. Interestingly, when
we compared the interfaces of these two types of hubs, we
observed that they had different compositions. Interfaces of multi-
interface hubs were usually similar to non-hub interfaces (data not
shown). On the other hand, interfaces of single-interface hubs were
more polar and less charged than multi-interface hubs and non-
hub proteins (See the second lines in each row of Table 3).
Gene clustering based on phenotype information,
molecular function or biological process
The most populated phenotypes observed among cancer genes
in iSPIN are leukemia, breast cancer and colorectal cancer, for
which there are 55, 22 and 23 related interactions in iSPIN,
respectively. Phenotype information was obtained from OMIM
[38] which is a compendium of human genes and genetic
phenotypes. We compared the interface properties of these cancer
related interactions with the same number of interfaces of non-
cancer interactions. For all of the phenotype groups, cancer
related interfaces showed a reduction in interface ASA and DASA
compared to noncancer ones. In addition, cancer related interfaces
were more planar and less tightly packed.
If the difference in interface properties is important enough, it
would be possible to classify a protein as cancer-related or non-
cancer by analyzing its interface. Thus, to check whether the data
on interface properties can be assessed for classification purposes,
we used Weka [39], a machine learning software for data analysis.
The training sets included equal number of cancer-related and
non-cancer interfaces. The experiments were performed using 10-
fold cross validation with several classifiers using four interface
features; interface ASA, DASA, planarity and gap volume index.
(See Methods for the details of the classification procedure) For
example, using support vector machine (SVM) as the classifier
algorithm, interfaces were ranked as cancer or noncancer related
with an accuracy of 61%, 71% and 67% for leukemia, breast
cancer and colorectal cancer, respectively. The relatively poorer
accuracy of leukemia might be the outcome that there are many
distinct subgroups of leukemia which we combined all in one here.
The results obtained using SVM classifier are summarized in
Structural Cancer Protein Interaction Network
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information (Text S1).
We also classified the genes in iSPIN according to the molecular
function and biological process of each protein obtained from the
Gene Ontology slim terms [40]. Among the most common
molecular functions were signal transducer activity, catalytic
activity, nucleic acid binding and transcription regulator activity.
Interfaces were classified as cancer related with an accuracy of
53%, 58%, 58% and 63% for signal transducer activity, catalytic
acitivity, nucleic acid binding and transcription regulator activity,
respectively. For the last three molecular functions, interface
properties showed noticeable differences for cancer and noncancer
interactions. However, for signal transducer activity function (65
cancer related-65 noncancer interfaces), the interface properties
were quite similar. We observed that cancer/noncancer interfaces
can be distinguished to a greater extent when the genes are
classified according to common phenotype rather than molecular
function. For the common phenotype case, in our interface
datasets, only cancer genes share the phenotype and noncancer
genes would have different phenotype properties. On the other
hand, for molecular function case, all genes share the same
molecular function irrespective of being cancer/noncancer. The
relatively poor classification performance by using molecular
functions indicates that functionally related proteins might have
similar interface characteristics regardless of being cancer-related.
Similarly, no discriminative characteristics between cancer-related
and noncancer interface datasets were observed when the proteins
were classified according to the biological processes.
The last four rows of the Table 4 shows the results of
classification performances without grouping genes according to
their phenotypes or functions. When we used all the data in iSPIN
(with an unbalanced training set), the performance is poorer than
the clustered cases. However, when a more appropriate method
(adaboost instead of SVM) was used, comparable performances
were obtained (Text S1).
Topological properties of the networks and relationship
with essentiality
Topological properties of protein-protein interaction networks
are shown to be useful to characterize proteins functionally [41] and
to understand molecular mechanisms of diseases [3,4]. To address
the topological properties of each of our network, we calculated the
degree distribution of proteins, which is a measure of the number of
proteins’interaction partners. In Figure2, the topological properties
are visualized for SPIN and listed in Table 5. For each network, the
degree distribution of the proteins decreases following a power-law
(P(k) ,k
c where k is the number of partner proteins). This implies
that the networks have scale-free properties [42]. The average
number of neighbors is the average degree of a node in the network.
On average, proteins in SPIN have 6.24 interaction partners. A
normalized version of average degree is the network density
showing how densely the network is populated with edges. When
structure information was integrated, network density increased.
This might indicate that less connected nodes in PIN might be
absent in PDB (Table 5). In Figure 2B, the average clustering
coefficient, which is a measure of proteins to form clusters in the
network [42] is shown. The average clustering coefficient decreases
as the number of protein interactions increases, since sparsely
connected proteins are neighbors of highly connected proteins (hub
proteins). For the hub proteins, the number of neighbors increased,
however, the number ofconnected pairsdidnot increase asmuchas
the number of neighbors which caused the average clustering
coefficient to decrease. This behavior indicates a hierarchical
organization in the protein interaction network [42]. In Figure 2B,
we see an exception for this case, although some nodes are highly
connected,their average clustering coefficients arealso high (.0.30)
(upper right corner of the figure). This indicates the occurrence of
dense subnetworks, in which hubs mostly interact with other hub
proteins.(Such subnetworks inSPIN areexplainedand visualized in
the next section) In Figure 2C, the topological coefficient which is a
relative measure for the extent to which a protein shares neighbors
with other proteins, [43] is displayed. The decreasing behavior of
the topological coefficient as the number of interactions of a protein
increases confirms the modular network organization; neighbors of
hub proteins are not more connected than the neighbors of sparsely
connected proteins. Figure 2D shows the shortest path length
distribution and indicates that proteins are closely linked. The
topological properties of other networks (PIN, cPIN, cSPIN, iSPIN,
ciSPIN) showed similar trends to those of SPIN explained above.
When cancer related networks were compared with the whole
Table 3. Average interface properties of hub and nonhub involved interactions. 6 in brackets refers to standard deviation. The
first and second lines in p-value column represent the comparison of hub/non-hub and single-interface hub/non-hub interactions,
respectively.
Interface property
Hub-involved
All hubs Single-interface hubs Nonhub-involved p-value (at a=0.05)
DASA (A ˚2) 1011.0 (6434)
1022.1(6374)
1459.9 (61484) 0.0004 0.003
Interface ASA (A ˚2) 2230.0 (61326)
2228.1(61178)
2943.9 (62691) 0.0030 0.01
Planarity (A ˚) 2.82 (61.13)
2.97(61.13)
3.34 (61.72) 0.0099 0.18
Gap Volume Index 2.72 (61.40)
2.53(61.06)
2.49 (61.48) 0.0580 0.39
% Polar residues in interface 30.5 (614.5)
32.5 (614.6)
29.9 (613.3) 0.80 0.11
% Non-polar residues in interface 28.0 (613.3)
28.6(612.2)
28.1 (613.1) 0.77 0.59
% Charged residues in interface 41.5 (616.4)
38.8(60.16)
42.0 (615.4) 0.77 0.03
doi:10.1371/journal.pcbi.1000601.t003
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iSPIN), the average clustering coefficient values were lower; i.e., the
proteins have a lower tendency to form clusters. This is reasonable
since cancer proteins are the key nodes that link different pathways
and they spread throughout the network to function in these
pathways. For example, the Cancer Cell Map (http://cancer.
cellmap.org/cellmap/), which is a collection of human-focused
cellular pathways implicated in cancer, contains ten pathways each
having around 100–400 interactions and cancer genes usually
function in more than one pathway. Another parameter related to
shortest path length is network diameter, which is the largest
shortest path length between two nodes providing information
about the accessibility of the nodes. The network parameters
calculated for each network are displayed in Table 5.
Topological role & functional distribution of cancer and
hub proteins in SPIN and PIN
Functionally related proteins are more connected than ran-
domly chosen protein pairs [43]. Here, we analyzed the
distributions of molecular function of cancer and noncancer
proteins and biological process in which they are involved (shown
Table 4. Cancer/noncancer classification analysis and statistical test results for iSPIN interface data, iSPIN clustered data according
to phenotype, molecular function or biological process. In the first column, cr stands for cancer-related interfaces and ncr stands
for noncancer interfaces. The second column gives the classification performances; first line is accuracy and second line is weighted
precision value. The third column lists features (mean values, standard deviations) used in classification for cancer and noncancer
interfaces. The last column is the significance of mean values and standard deviations.
Group
Accuracy
Precision
Cancer/Noncancer
Interface ASA
DASA
Planarity Gap V.I.
p-value
(at a=0.05)
Phenotype: Leukemia (55 cr – 55 ncr) 0.61
0.64
1863.3 (61207.9)/2425.8 (61207.9)
850.86 (6346.91)/1147.5 (6633.31)
2.482 (60.762)/2.939 (61.390)
2.862 (61.285)/2.423 (60.985)
0.0007
0.0287
0.4128
0.1125
Phenotype: Breast cancer (22 cr – 22 ncr) 0.71
0.77
1908.5 (6623.82)/2672.2 (61257.3)
822.87 (6290.40)/1343.6 (6670.89)
2.361 (60.601)/3.269 (61.455)
2.306 (61.138)/2.239 (60.9478)
0.03
0.0047
0.1079
0.9159
Phenotype: Colorectal cancer (23 cr – 23 ncr) 0.67
0.73
1923.8 (6533.87)/2790.4 (61352.8)
978.07 (6325.92)/1428.5 (6771.66)
2.781 (61.003)/3.472 (61.724)
2.547 (61.748)/2.229 (60.9272)
0.0167
0.04
0.2917
0.6211
Molecular function: Signal Transducer Activity (65 cr – 65 ncr) 0.53
0.55
2226.3 (61370.7)/2454.7 (61726.1)
989.50 (6423.20)/1033.5 (6451.70)
2.886 (61.347)/2.805 (61.141)
2.764 (61.178)/2.612 (61.201)
0.3814
0.6282
0.8559
0.3801
Molecular function: Catalytic Activity (84 cr – 84 ncr) 0.58
0.62
2042.8 (6823.69)/2758.1 (62233.0)
963.32 (6340.09)/1277.1 (6627.45)
2.916 (61.446)/3.171 (61.320)
2.496 (61.066)/2.577 (61.232)
0.0085
0.0006
0.1078
0.6185
Molecular function: Nucleic Acid Binding (31 cr – 31 ncr) 0.58
0.60
2229.9 (61504.6)/2567.5 (6870.98)
913.30 (6382.07)/1308.0 (6508.19)
2.717 (61.458)/3.217 (61.193)
2.240 (60.959)/1.934 (61.031)
0.0188
0.0016
0.0324
0.1471
Molecular function: Transcription Regulator Activity (23 cr – 23 ncr) 0.63
0.64
2668.6 (62031.3)/2877.9 (61250.0)
1106.0 (6548.00)/1504.1 (6587.72)
2.615 (60.897)/3.600 (61.486)
2.442 (61.091)/2.011 (61.111)
0.1803
0.0224
0.0182
0.1732
All data in iSPIN (363 cr – 186 ncr) 0.66
0.44
2210.9 (61476.0)/2628.1 (61947.5)
1009.1 (6611.77)/1243.0 (6942.69)
2.843 (61.285)/3.056 (61.233)
2.760 (61.482)/2.543 (61.275)
0.0006
6.2e-005
0.0429
0.0798
iSPIN equal # of instances (186 cr -186 ncr) 0.54
0.54
2199.6 (61436.5)/2628.1 (61947.5)
1029.7 (6732.01)/1243.0 (6942.69)
2.954 (61.492)/3.056 (61.233)
2.820 (61.651)/2.543 (61.275)
0.0058
0.0013
0.1937
0.1088
iSPIN PDB – PDB interfaces (55 cr – 55 ncr) 0.56
0.56
1917.2 (6884.04)/2471.3 (61240.9)
911.41 (6489.56)/1258.8 (6740.15)
2.723 (61.316)/3.298 (61.424)
3.018 (61.833)/2.278 (61.149)
0.03
0.0089
0.0228
0.0214
iSPIN predicted interfaces (131 cr – 131 ncr) 0.57
0.58
2186.6 (61146.4)/2694.0 (62177.8)
989.81 (6347.54)/1236.3 (61018.3)
2.727 (60.880)/2.955 (61.135)
2.584 (61.020)/2.654 (61.312)
0.0051
0.0035
0.2427
0.7967
doi:10.1371/journal.pcbi.1000601.t004
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proteins and hub proteins are over-represented in protein binding,
signal transducer activity, kinase activity and transcription
regulator activity. Previously, Jonsson et al [3] performed a cluster
analysis of the human interactome (the so-called ‘PIN’ in this
study). They observed that cancer proteins, on average, belonged
to more highly populated clusters compared to non-cancer
proteins and were involved in multiple cellular processes. Here,
we performed a clustering analysis of SPIN using MCODE [44]
and obtained subnetworks (see Methods). The first six subnet-
works, which were ranked as top six, are shown in Figure 4
(proteins are colored according to four categories; cancer-hub,
noncancer-hub, cancer-nonhub, noncancer-nonhub and shown in
purple, green, blue and white color, respectively). These
subnetworks were compared to SPIN to check if some molecular
functions and biological processes were over/under-represented.
We observed a common molecular function; signal transduction
activity, which is over-represented in three of the subnetworks
(subnetworks 2, 4 and 6). In terms of topological properties, these
subnetworks showed similarity in the way that they contain hub
proteins; subnetworks 2 and 4 contain only hub proteins (cancer or
noncancer) and in subnetwork 6; 14 nodes out of 17 are hubs.
Thus, we wondered if hub proteins prefer to interact with other
hub proteins. Maslov and Sneppen [45] argued that hub proteins
do not tend to interact with other hub proteins, but rather prefer
to interact with lowly connected proteins. In contrast, Coulomb et
al. [46] found that the average degree of nearest neighbors is
independent of node degree. We calculated the average degree of
hub proteins; we divided the partners of hub proteins into two
class; hubs and nonhubs. We found that, on average, hub-nonhub
average degree (7.04) was greater than hub-hub average degree
(5.06) indicating that hubs do not have a preference to interact
with other hub proteins in SPIN. On the other hand, we found
Figure 2. Topological properties of SPIN. (A) Degree distribution of proteins, R
2=0.914 for power law fit (B) Average clustering coefficient (C)
Topological coefficients (D) Shortest path length distribution.
doi:10.1371/journal.pcbi.1000601.g002
Table 5. Network parameters calculated for each network.
Parameter Network type
PIN cPIN SPIN cSPIN iSPIN ciSPIN
Number of nodes 13584 8990 1702 1303 534 381
Number of edges 85083 27413 5312 3221 549 363
Clustering coefficient 0.109 0.080 0.143 0.113 0.089 0.051
Characteristic path length 4.086 4.589 4.661 5.064 9.533 8.221
Network diameter 11 11 11 11 23 20
Network density 0.001 0.001 0.004 0.004 0.004 0.005
Avg. number of neighbors 11.27 5.45 6.24 4.94 2.11 1.97
doi:10.1371/journal.pcbi.1000601.t005
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than interacting with non-hubs. Cancerhub – hub average degree
and cancerhub – nonhub average degree were 8.49 and 7.16,
respectively. The same results are valid for PIN as well. The results
support that cancer proteins play central role in the networks and
show distinct topological properties than noncancer proteins.
Hubs are more important than bottlenecks to
characterize essential genes
Recently, Yu et al (2007) [47] have analyzed the significance of
hubs, proteins with high degree distribution, and bottlenecks,
proteins with high betweenness, in the yeast protein-protein
interaction network and regulatory networks. They have
investigated which quantity, degree distribution or betweenness,
is a better predictor of protein essentiality. It was reported that in
directed networks, for example in regulatory networks, between-
ness is a more important feature in terms of essentiality. In yeast
regulatory networks, Yu et al. observed that bottlenecks (both
hub-bottlenecks and nonhub-bottlenecks) are generally products
of essential genes, whereas hub-nonbottlenecks are not essential
at all. When they analyzed the protein-protein interaction
network in yeast (undirected network), they found that degree
is a much better predictor of essentiality than betweenness since
hub-nonbottlenecks are much more essential than nonhub-
bottlenecks.
We also investigated how degree and betweenness correlate
with essentiality in protein-protein interaction network in human.
We classified all proteins into four categories; hub-bottleneck, hub-
nonbottleneck, nonhub-bottleneck and nonhub-nonbottleneck.
Figure 5 (A, B) show the essentiality of different categories of
proteins, in PIN and in SPIN. In addition to these networks, a
random network, which is the same size as SPIN and has the same
average degree distribution, was generated from PIN. First a
protein from PIN was selected randomly. Then, some of the
interactions of this protein were randomly selected. The same
procedure was applied to the newly selected neighbors until the
network size and average degree distribution values were satisfied.
As shown in Figure 5, the hub-bottlenecks were found to be the
most essential category in all networks. The fraction of essential
gene percentages for hub-bottlenecks in SPIN, random network
and PIN were 54%, 35% and 31%, respectively. Hub-nonbottle-
necks were found to be more essential than nonhub-bottlenecks;
i.e. degree is a more important parameter in terms of essentiality in
PIN, SPIN and the random network. This finding confirms the
hypothesis stated by Yu et al (2007) [47].
Essentiality fractions in SPIN were much higher than the ones
in PIN (y-axes of Figure 5A and Figure 5B). The reason for higher
fraction of essential genes in SPIN may stem from a possible bias
towards well-studied proteins for which structural information is
available. Another reason could be a physical bias due to the fact
that PIN is a large-scale data. To investigate the reason for this
bias, we generated a random network from PIN, which is the same
size as SPIN and has the same average degree distribution.
Figure 5C displays the fraction of essential genes in this random
network. We observed that the fraction of essentiality was higher
for the random network than for PIN. However, the values were
still much smaller than those for SPIN. Thus, we concluded that
the reason for higher essentiality in SPIN probably arose from a
bias towards well-studied proteins rather than a physical bias.
The essentiality of cancer hubs is significantly higher
than that of non-cancer hubs
Hub proteins are more likely to be encoded by essential genes
[48,49]. In addition, somatic cancer genes are more likely to
Figure 3. Molecular function and biological process distribution of cancer & non-cancer genes. (A) Molecular distribution of genes in
SPIN (B) Molecular distribution of genes in PIN (C) Biological process distribution in SPIN (D) Biological process distribution in PIN.
doi:10.1371/journal.pcbi.1000601.g003
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essential cancer genes are more likely to encode hub proteins than
non-essential cancer genes. Thus, we classified all cancer genes in
the networks as hub and non-hub, and observed that cancer-hubs
were more essential than cancer-nonhubs, which confirms our
above hypothesis; essential cancer genes are more likely to encode
hub proteins than non-essential cancer genes. The essentiality
percentage in each category, hubs and non-hubs are 50% (total
532) and 37% (total 650) for PIN, 66% (total 158) and 44% (total
286) for SPIN, 47% (total 85) and 37% (total 140) for random
network, respectively. The essentiality percentage values are
visualized in Figure 6.
Another question is whether cancer or non-cancer hubs are
more essential. We found that when we classified the hub proteins
as cancer-hubs and non-cancer-hubs, there was a significant
difference in essentiality. In SPIN, there were 158 cancer hubs,
66% of which were essential. In contrast, only 28% of the 197
non-cancer hubs were essential. Similarly, in both PIN and the
random network cancer hubs were much more essential than non-
cancer hub proteins. In PIN the 50% of the 532 cancer hubs were
essential, whereas only 24% of the 1801 total non-cancer hub
proteins were essential. In the random network, 47% of 85 total
cancer hubs were essential, whereas 30% of 246 total non-cancer
hub proteins were essential. The fraction of essential genes in
cancer hubs and non-cancer hubs for each network are shown in
Figure 6. The numbers of essential and nonessential genes are
given for each category in PIN, SPIN and random network as
supplementary information (Text S1). We should note that
essential gene list is obtained on optimal growth/living conditions
and if the conditions are changed, for example in case of a disease
state such as cancer, a nonessential gene would become essential
or vice versa. However, due to the lack of data on essential gene
information in cancer cells, we assigned the same set of essential
genes to cancer state and non-cancer state. Recently, Luo et. al
[50] had an effort to identify the genes essential for growth and
related phenotypes in different cancer cells by genetic screening
strategy. Since a small fraction of these genes appear in our
networks, it is not appropriate to use them in statistical analysis.
Multi-interface and single-interface proteins:
Correspondence with degree, betweenness and
essentiality
As discussed above, some hubs are single-interface, that is, they
communicate with their partners by using the same interface,
whereas others are multi-interface. We investigated to which
category, hub-bottleneck or hub-nonbottleneck, multi-interface
and single-interface proteins belong. We observed that multi-
interface proteins generally corresponded to hub-bottleneck
Figure 4. Sub-networks in SPIN. SPIN is clustered into sub-networks, proteins are classified into four categories; cancer-hub, noncancer-hub,
cancer-nonhub, noncancer-nonhub are displayed in purple, green, blue and white color, respectively. Over-represented molecular functions (if any)
are shown for each sub-network.
doi:10.1371/journal.pcbi.1000601.g004
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proteins are hub-bottlenecks.) When the single-interface proteins
were considered, the percentage of hub-bottleneck correspondence
decreased to 59%. In other words, 58% of hub-bottleneck proteins
were multi-interface and 42% are single-interface. Previously we
showed that hub-bottlenecks were the most essential category of
proteins in SPIN and in PIN. Here, in the structural interface
network, we found that the essentiality of multi-interface hubs
(68%) was higher than that of single-interface (52%). This result
agrees with a previous finding [19] indicating that the number of
interfaces leads to higher essentiality. In addition, Aragues et al.
(2007) found that yeast hubs with multiple interacting motifs were
more likely to be essential than hubs with one or two interacting
motifs [51]. Being more essential and corresponding mostly to
hub-bottlenecks, multi-interface hubs are the key points in the
protein-protein interaction network.
Cancer proteins in our network are more enriched in multi-
interface proteins: 56% of cancer proteins are multi-interface,
while 44% being single-interface. This is reasonable since on
average, cancer proteins are longer [52] with larger surface areas.
To cope with many interactions at the same time, they tend to be
multi-interface hubs with distinct interfaces interacting with
different proteins. Although cancer proteins tend to have more
than one distinct interface, we found that on average their
interfaces were smaller, which can indicate that their binding
behavior acts similar to that of hub proteins. In addition, the
average number of interfaces of cancer multi-interface hubs and
noncancer multi-interface hubs were 2.5 and 2.3, respectively.
Cancer multi-interface hubs have a greater average number of
interfaces. The correspondence of hub-bottlenecks and hub-
nonbottlenecks to multi/single interface proteins and the essenti-
ality percentage in cancer/noncancer & multi/single interface
proteins are displayed in Table 6.
Case Studies
The interface information is an asset in predicting which
interactions can and cannot co-exist. In other words, it will help
to deduce which interactions can occur simultaneously and which
are mutually excluded. Addressing this question may add a fourth
dimension to interaction maps, that of sequence of processes.
Including the sequence dimension in structural networks is an
immense asset; transforming network node-and-edge maps into
cellular processes, and assisting in the comprehension of cellular
pathways and their regulation. Here, to characterize the interac-
tions and to infer the order of processes, we present two case studies,
first a multi-interface cancer protein and an inhibitor of the protein,
and second, a single-interface cancer protein in iSPIN. For the first
case study, multi-interface cancer protein, most of the interactions
are simultaneously possible whereas for the latter, the interactions
are mutually exclusive. In addition to geometrical justification for
simultaneous and exclusive interaction behavior, dynamic nature of
Figure 5. Essentiality of different categories of proteins. A) Essentiality in PIN. B) Essentiality in SPIN. C) Essentiality in random network.
doi:10.1371/journal.pcbi.1000601.g005
Figure 6. Essentiality of proteins classified as cancer-hub,
cancer-nonhub and non-cancer-hub in SPIN, PIN and random
network.
doi:10.1371/journal.pcbi.1000601.g006
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complexes were refined using FiberDock http://bioinfo3d.cs.tau.
ac.il/FiberDock/, which models both side-chain and backbone
flexibility. Next, to obtain a quantitative estimation of the
importance of the interactions, we used FoldX algorithm [53,54]
for calculating the interaction energy between two proteins, which
servesasanestimateforthe affinityofthe interactions.InFigure7,a
visualization of iSPIN is displayed together with multi-interface and
single-interface proteins.
A multi-interface hub: ErbB3 (Her3)
Here we show how the interface information is used to deduce
which interactions can and cannot co-exist. If each interaction
partner of a hub protein uses a distinct interface on the hub while
interacting, then these interactions are more likely to occur
simultaneously. Inaddition,thequaternarystructureofthecomplex
should be considered carefully to ensure that the interaction
partners do not collide. To demonstrate this idea, we present a so-
called ‘multi-interface’ hub protein: ERBB3 (or HER3), which is
one of the hub proteins in SPIN. The receptor tyrosine-protein
Table 6. Correspondence of HB, H-NB to Multi/single
interface proteins and Essentiality % in cancer/noncancer &
Multi/single interface proteins HB and H-NB refer to hub-
bottlenecks and hub-nonbottlenecks, respectively.
HB H-NB Total
Multi-interface # 30 12 42
Single-interface # 22 15 37
Essentiality percentage (%)
Multi-interface 68
Single-interface 52
Cancer 76
Non-cancer 42
doi:10.1371/journal.pcbi.1000601.t006
Figure 7. Representation of iSPIN. The nodes colored in green and red are multi-interface hubs and single-interface hubs, respectively. In the
zoomed representation, the interactions of a multi-interface hub; ERBB3 is displayed.
doi:10.1371/journal.pcbi.1000601.g007
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subfamily and acts as a heregulin receptor and as an epidermal
growth factor receptor. Amplification of this gene and/or
overexpression of its protein have been reported in numerous
cancers, including prostate, bladder, and breast tumors [55].
According to the KEGG database [56], ERBB3 functions in the
ErbB signaling pathway and the Calcium signaling pathway. In the
ErbBsignalingpathway,NRG1(neuregulin1,heregulin),which isa
direct ligand for ERBB3, binds and activates ERBB3. We modeled
this interaction using the PDB accession codes 1hae_A (NMR
structure of heregulin) for NRG1 and 1m6b_A (crystal structure of
ERBB3 taken from a homodimer structure) for ERBB3, respec-
tively. PRISM results indicate that these two proteins (1hae_A and
1m6b_A) interact, and using NOXclass [57], we found that the
interaction is biologically relevant. After applying flexible refine-
ment by FiberDock, FoldX server [53,54] was used to calculate the
interaction energy (24.08 kcal/mol). Predicted binding sites on
both proteins and interacting residues for NRG1-ERBB3 interac-
tion are shown in Figure 8A. The interaction was experimentally
studied in a previous study by Jones et al (1998) [58], where they
mutated individual residues of the egf domain of heregulinb (the
same as egf domain of heregulina-NRG1- except four residues) to
alanine in order to determine residues critical for binding receptors
andinitiating signaltransduction.They found that whenHis
2,Leu
3,
Val
4, Phe
13, Val
15–Gly
18,V a l
23, Arg
31,L y s
35, Gly
42–Gln
46 residues
were changed to alanine, binding affinity for ERBB3 was
dramatically reduced. We observed that most of these critical
residues were included in our predicted binding site for NRG1. In
Figure 8A, these residues are labeled.
In the ErbB signaling pathway, NRG1 also binds to ERBB4,
and the binding affinity was reported to be similar to that of
ERBB3 [58]. According to our interface prediction, ERBB3 and
ERBB4 binding interfaces on NRG1 are overlapping; i.e., the
same binding site is used for the ERBB3 and ERBB4 interactions.
Therefore, NRG1-ERBB3 and NRG1-ERBB4 interactions are
mutually exclusive; they cannot occur at the same time.
According to the calcium signaling pathway in KEGG [56],
ERBB3 interacts with PLCG1. Although the interaction is not
reported in public databases as in DIP [59], BIND [60], in a recent
study, it was observed on protein microarrays [61]. PLCG1
(Phospholipase C-gamma-1) is a major substrate for heparin-binding
growth factor 1 (acidic fibroblast growth factor)-activated tyrosine
kinase. The PDB structure of SH3 domain of PLCG1 is 1hsq. The
predicted interface residues of ERBB3-PLCG1 (1m6b_A-1hsq_A)
interaction are displayed in Figure 9 labeled as A. The interaction
energy between proteins was calculated as 212.62 kcal/mol.
The two other possible interactions of ERBB3 occur with
EPOR (Erythropoietin receptor) and ACK1 (Activated CDC42
kinase 1) according to the human interactome constructed by
Jonsson and Bates. No experimental confirmation is available for
these interactions yet, however, they have high confidence scores
to occur in Jonsson and Bates’s network [3]. These interactions of
ERBB3 were also predicted to interact and further investigated.
Subcellular location for ERBB3, EPOR and ACK1 is the cell
membrane. EPOR and ERBB3 function as single-pass type I
membrane protein. The predicted interfaces for these interactions
are illustrated in Figure 9, labeled as B and C.
Our results show that ERBB3 uses at least three different binding
sites while interacting.Oftheseinteractions,weproposethat ERBB3
cannot interact with EPOR and ACK1 at the same time, because if
we model the quaternary structure of ERBB3-EPOR-ACK1
complex, the residues of EPOR and ACK1 will collide. Thus, they
Figure 8. Representation of ERBB3-NRG1 interaction schematically. The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and
NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively. The transparent surface represents the interface region. The
labeled residues (represented by their Ca atoms) of 1hae_A are reported to be critical for binding in a previous work [58]; i.e. when they are mutated
to alanine, the binding affinity for ERBB3 was significantly reduced. B) HER3 (blue) – pertuzumab heavy chain (yellow) is shown. Pertuzumab shares
the same interface with NRG1 (see ‘‘An inhibitor affecting Erb signaling pathway: pertuzumab’’ section).
doi:10.1371/journal.pcbi.1000601.g008
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proteins are dynamic, and a hinge-like motion of the two domains of
ERBB3 can eliminate the collision between EPOR and ACK1.
If we compare their interaction energy, which were calculated
as 216.37 kcal/mol and 26.12 kcal/mol for ERBB3-EPOR and
ERBB3-ACK1, respectively, ERBB3-EPOR interaction is more
favorable. In addition, when ACK1 interacts with ERBB3, it also
blocks the interaction of NRG1. In terms of geometrical and
energy concern, the simultaneously possible interactions would be
ERBB3-PLCG1 (interaction energy: 212.62 kcal/mol) and
ERBB3-EPOR, for which the affinity predictions are higher than
those of other interactions.
An inhibitor affecting Erb signaling pathway:
pertuzumab
To illustrate the importance of the sequence of processes, we
further focused on ERBB3 interactions and investigated how it
functions if its partners use the same interface while interacting. In
this case the interactions cannot occur at the same time. In
general, the HER/erbB family of proteins (EGFR (HER1), HER2,
HER3, and HER4) activate intracellular signaling pathways in
response to extracellular signals [55]. The signaling mechanism is
as follows: first EGFR and HER3 are activated by ligand binding
(ligands are EGF and NRG1 for EGFR and HER3, respectively),
and then EGFR or HER3 forms heterodimer with HER2 followed
by the transphosphorylation of their C-terminal tails. Heterodimer
formation of HER2 with EGFR and HER3 induces different
pathways. For example, The PI3K/Akt pathway, which is
critically important in tumorigenesis, is activated by phosphory-
lated HER3. The deregulation of signaling functions of the HER
family of proteins causes cell transformation and tumorigenic
growth [55]. In anti-cancer drug development, EGFR and HER2
proteins are the main targets. For example, pertuzumab, which
targets HER2 dimerization region, attempts to inhibit HER2-
HER3 or HER2-EGFR interactions.
In a recent study [62] investigating the effect of pertuzumab inlung
cancer cells, it was found that pertuzumab blocked NRG1-stimulated
phosphorylation of HER3. In contrast, it failed to block epidermal
growth factor (EGF)-stimulated phosphorylation of EGFR in human
non-small cell lung cancer cell line 11_18. This is somewhat
interesting sinceHER2 uses the same bindingregion fordimerization
with HER3 and EGFR and this region is assumed to be blocked by
pertuzumab. However, it may be hypothesized that in addition to its
inhibitingeffectondimerizationregionofHER2,pertuzumabshould
also affect the ligand binding region of HER3 and EGFR, namely
HER3-NRG1 interaction and EGFR1-EGF interaction.
In order to investigate the effect of pertuzumab on HER3-
NRG1 interaction, pertuzumab heavy chain (PDB ID 1s78) was
docked to HER3 (PDB ID 1m6b). The docked conformation is
visualized in Figure 8B. NOXclass results indicate that the docked
conformation is biological (biological score is 70%). Although
HER2 and HER3 are similar in structure, the interface region on
HER2 and HER3 through which the interaction with pertuzumab
occurs are not exactly the same in structure, but rather use
overlapping regions. We observed that pertuzumab binding
interferes with NRG1 binding region, which indicates that
pertuzumab may also block ligand binding to HER3 and thus
prevent HER3 activation. 36% of interface residues (8 out of 22) of
HER3-NRG1 interface are also used by pertuzumab, which
makes the interactions of HER3 with NRG1 and pertuzumab
mutually exclusive. Both interactions are visualized together and
the black surface region shows the shared interface region (see
Text S1).
Thus, our results indicate that pertuzumab may block the
NRG1 interaction region of HER3. Probably, pertuzumab would
not affect the binding of EGF to EGFR and thus it is not effective
against (EGF)-stimulated phosphorylation of EGFR in the
aforementioned lung cancer cells.
A single-interface hub: RAF1
If the interaction partners of a hub protein use the same
interface region, then these interactions are more likely to be
mutually exclusive. For example, in iSPIN, RAF1 has 9
interactions partners which compete for binding. RAF proto-
oncogene serine/threonine-protein kinase participates in the
transduction of mitogenic signals from the cell membrane to the
nucleus and protects cells from apoptosis mediated by STK3.
Among its interaction partners, we were able to predict interaction
interfaces for CDC25, YWHAZ and MAP2K2, for which
interaction energies were calculated as 21.91 kcal/mol,
Figure 9. Ribbon diagram and interface representation of ERBB3 interactions with PLCG1, EPOR and ACK1. ERBB3 (1m6b_A), PCLG1
(1hsq_A), EPOR (1eer_B) and ACK1 (1u46_A) are colored in blue, red, pink and orange respectively. Interface residues are shown as spheres. (A)
ERBB3-PLCG1 interaction. (B) ERBB3-EPOR interaction. (C) ERBB3-ACK1 interaction.
doi:10.1371/journal.pcbi.1000601.g009
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that all interaction energies were calculated for the comparison of
the interactions and the numeric values may not be precise since
these are not experimental results.
Interaction with RAP1A is a known structure with PDB ID 1c1y.
Additional possible interactions of RAF1 in iSPIN are with RALA,
DIRAS1, DIRAS2, CCNA2 and RRAD. Although the interface
region is not completely the same for each interaction partner, most
interface residues are shared (the shared percentage .20, which is
the cutoff value for assigning the interface as distinct or same).
Thus, these interactions cannot occur at the same time. All three
interactions (RAF1-CDC25A, RAF1-MAP2K2, RAF1-YWHAZ)
are cancer-cancer related and their affinities are lower compared to
ERBB3-EPOR and ERBB3-PLCG1 interactions which are
cancer-noncancer related and simultaneously possible. Friedler
et al. (2005) [63] observed a highly electrostatic binding site in a
cancer protein, p53, interacting with Rad51 and other peptide
sequences with different affinity. The results imply that cancer
proteins and hubs interact with their partners with high specificity
and low affinity. Therefore, it becomes possible for them to bind to
many different proteins with varying affinity. Three predicted
binding sites are illustrated in Figure 10. In Text S1, RAF1 is
displayed with its three binding partners: RAF1 (1c1y_B) is shown
in blue, the partners YWHAZ (1qja_A), MAP2K2 (1s9i_A) and
CDC25A (1c25_A) are colored in red, cyan and purple
respectively. The interface is highly shared which hypothesize that
RAF1 is a single-interface protein and involved in mutually
exclusive interactions. RAF1 is a protein kinase and a signaling
protein; thus, it probably interacts transiently with most of its
targets. A recent study confirms this interaction behavior of RAF1,
showing that the binding of Cdc25 and of Rad24 (14-3-3 homolog
that is important in the DNA damage checkpoint) to Raf-1 is
mutually exclusive [64].
Conclusion
In this work, we analyzed cancer proteins and hub proteins in
human protein-protein interaction networks from a structural
perspective, and by considering their global behavior in the
network.
Integrating three-dimensional protein structures into human
protein-protein interaction network revealed important aspects
about hubs and cancer-related proteins. Interface property analysis
identified thestructuraltendenciesofcancerproteinsthatassisttheir
binding to multiple proteins. Interfaces of cancer proteins, on
average, are smaller in size, more planar, less tightly packed and
more hydrophilic than those of non-cancer proteins. Within
phenotypes, for breast cancer, colorectal cancer and leukemia,
interface properties were found to be discriminating from non-
cancer interfaces with an accuracy of 71%, 67%, 61%, respectively.
Hub proteins also have smaller, less tightly packed and more
planar interfaces than non-hub proteins. Similar or overlapping
binding sites should be used repeatedly in hub proteins, single
interface hub proteins, making them promiscuous. Alternatively,
multi-interface hub proteins make use of several distinct binding
sites to bind to different partners. Interfaces of multi-interface hubs
are usually similar to non-hub interfaces. On the other hand,
interfaces of single-interface hubs are more polar and less charged
than multi-interface hubs and non-hub proteins.
In addition cancer-related proteins tend to interact with their
partners through distinct interfaces, corresponding mostly to
multi-interface hubs, which comprise 56% of cancer-related
proteins, and constituting the nodes with higher essentiality in
the network (76%). Cancer proteins are more enriched in multi-
interface proteins: 56% of cancer proteins are multi-interface,
while 44% being single-interface. This is reasonable since it is
known that, on average, cancer proteins are longer with larger
surface areas. To cope with many interactions at the same time,
they tend to be multi-interface hubs with distinct interfaces
interacting with different proteins. Cancer multi-interface hubs
have a greater average number of interfaces.
We found that, on average, hub-nonhub average degree (7.04) is
greater than hub-hub average degree (5.06) indicating that hubs
do not have a preference to interact with other hub proteins in
SPIN. On the other hand, we found that cancer hubs prefer to
interact with other hub proteins rather than interacting with non-
hubs. Cancerhub – hub average degree and cancerhub – nonhub
average degree are 8.49 and 7.16, respectively. The same results
are valid for PIN as well. The results reveal the well known
information that cancer proteins play central role in the networks
and show distinct topological properties than noncancer proteins.
Finally, we illustrated, in detail, the interface related affinity
properties of two cancer-related hub proteins: Erbb3, a multi
interface, and Raf1, a single interface hub. The results revealed
that affinity of interactions of the multi-interface hub tend to be
higher than that of the single-interface hub. These findings might
be important in obtaining new targets in cancer as well as finding
the details of specific binding regions of putative cancer drug
candidates.
Figure 10. Ribbon diagram and interface representation of RAF1 interactions with YWHAZ, MAP2K2 and CDC25A. RAF1 (1c1y_B),
YWHAZ (1qja_A), MAP2K2 (1s9i_A) and CDC25A (1c25_A) are colored in blue, red, cyan and purple respectively. (A) RAF1-YWHAZ interaction. (B)
RAF1-MAP2K2 interaction. (C) RAF1-CDC25A interaction. Interaction interfaces of RAF1 through YWHAZ, MAP2K2 and CDC25A are highly
overlapping; the interactions are mutually exclusive.
doi:10.1371/journal.pcbi.1000601.g010
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Human protein-protein interaction and cancer-
associated protein interaction datasets
We studied the human interactome constructed by Jonsson &
Bates (2006) [3] and referred to this network as ‘PIN’. They used
an orthology-based method in which BLAST [65] searches were
run for the human genome against all proteins in the DIP [59]
and MIPS Mammalian Protein-Protein Interaction databases
[66]. They analyzed their putative interactions giving confidence
scores based on the level of homology to proteins found
experimentally to interact and the amount of experimental data
available. After ROC curve analysis, with a sensitivity of 85% and
specificity of 82%, the human interactome consisted of 108113
binary gene-gene interactions and 13584 genes. From these
interactions, the redundant ones, i.e. the interactions for which
the RefSeq ID corresponding to the same genes, were omitted.
Thereby, the network (PIN) consists of 85083 interactions. The
list of cancer genes was taken from the comprehensive census of
human cancer genes provided by Futreal et al (2004) [67]. 10724
interactions were cancer-related in this interactome. In addition,
we collected a set of known cancer genes from the Memorial
Sloan Kettering computational biology website CancerGenes
(http://cbio.mskcc.org/CancerGenes/Select.action) using the
queries of ‘‘tumor suppressor’’, ‘‘oncogene’’ and ‘‘stability’’ genes.
We combined that list with the known cancer genes of Futreal
et al. [67]. Thus, cancer related interactions number increased to
27413.
Mapping interactions to known 3D structures
We used Swiss-Prot Knowledgebase [68] to map the binary
interactions to known structures. The human genes for which 3D
structures are known were compiled from the Swiss-Prot
Knowledgebase. For each gene-gene interaction in the human
interactome, a known complex structure was searched. If a
known structure was not available for the interaction, we
searched for the structures of each gene and mapped each gene
to the corresponding structure as a single chain. If any of the
genes in the binary interaction did not have a structural
representation, then that interaction was omitted. For example,
in the human interactome, one of the binary interactions is
TP53-MDM2 interaction. The interaction is represented by a
known complex structure in PDB [28] as 1ycr. However, for the
TP53-MDM4 interaction, there occurs no known complex
structure. In this case, TP53 was represented by its correspond-
ing structure with the highest resolution for which the PDB ID is
1aie_chain A. Similarly, for MDM4, the structure is
2cr8_chainA. In total, 206 interactions were mapped to known
complexes. The summary of the mapping procedure is illustrated
in Figure 11.
The mapped protein-protein interaction network called the
‘‘structural protein interaction network’’ (SPIN) consists of 1702
nodes (proteins) and 5312 edges (interactions). From 5312
interactions, 206 interactions were mapped to known 3D
structures. Therefore, the interfaces of these 206 interactions were
known. On the other hand, the interfaces of the remaining 5106
interactions were left for further prediction.
Figure 11. Flowchart representation of the method of mapping interactions to 3D structures and generating iSPIN. The method is
applied for all the interactions in the human interactome (PIN).
doi:10.1371/journal.pcbi.1000601.g011
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1702 proteins, 466 of them were found to be encoded by cancer-
related genes (cancer gene information from Futreal et al. [67] and
the Memorial Sloan Kettering computational biology website
CancerGenes (http://cbio.mskcc.org/CancerGenes/Select.action),
the rest (1236) were taken as encoded by noncancer genes. As a
result, we defined the ‘cancer structural subnetwork’ (‘cSPIN’), as
the one consisting of cancer-cancer and cancer-noncancer gene
interactions. Our cSPIN contains 1303 proteins and 3221
interactions. The total number of proteins and interactions for
each network is summarized in Table 5.
Definition of hubs and bottlenecks
Degree represents the number of interaction partners of a
protein. Betweenness is a measure of the total number of shortest
paths going through a certain node or edge in the network [69].
We defined as hubs the proteins that are in the top 20% of the
degree distribution in PIN and SPIN. That corresponds to proteins
with $9 interactions. Accordingly, we defined bottlenecks as the
top 20% proteins with the highest betweenness values. (Varying
the threshold from 10% to 30% had no significant impact on our
results; see Text S1 for hub/non-hub interface statistics). To
calculate betweenness within the network, we used NetworkX
(NX) (https://networkx.lanl.gov/wiki), a Python package. Hubs
were classified as hub-bottlenecks and hub-nonbottlenecks accord-
ing to high betweenness or low betweenness, respectively.
Determination of essential human genes
Goh et al (2007) [2] predicted the essentiality of a human gene
using phenotype information of the corresponding mouse
orthologs. A human gene was defined as ‘‘essential’’ if a knock-
out of its mouse ortholog results in lethality. Here embryonic/
prenatal lethality and postnatal lethality are considered lethal
phenotypes, and the rest of the phenotypes are considered non-
lethal. We obtained the human-mouse orthology and mouse
phenotype data from Mouse Genome Informatics (http://www.
informatics.jax.org ) on May 10, 2008. Of 1702 proteins in our
SPIN, 1536 have mouse orthologs and phenotype information.
According to our classification, we found 497 genes to be essential
and the rest to be non-essential.
Predicting protein-protein interfaces in SPIN
PRISM (protein interactions by structural matching) [26,27] is a
web server to predict protein-protein interactions and protein
interfaces. The prediction algorithm uses structural and evolutionary
similarities to find possible binary interactions between proteins,
‘‘targets,’’ through similar known interfaces, ‘‘templates.’’ Here, target
proteins were the proteins in our SPIN dataset for which we wanted to
predict the interaction interfaces. As template interfaces, we used the
representative interfaces generated from the nonredundant data set of
protein-protein interfaces [13] available at http://prism.ccbb.ku.edu.
tr/interface , for which the interactions are biological according to
NOXclass [57] outputs. There are 1478 template interfaces.
The PRISM prediction algorithm starts by extracting the
surfaces of target proteins by invoking NACCESS [70]. Template
interfaces are split into their complementary partner chains and
these partners are structurally aligned with the surfaces of the
target proteins. Similarity between the target surface and one
partner of the template interface is measured using a scoring
function based on two factors. The first is structural similarity, in
which RMSD and residue match ratio between target protein and
the template interface is scored. The other factor considers
evolutionary similarity in which a hotspot match ratio is scored.
(Critical residues at the interface which account for the majority of
the binding free energy are called hotspots [71]. PRISM obtains
the information on hotspots from Hotsprint [72,73] a web server
for predicting hotspots at protein interfaces.) Then, combining
these scores, PRISM predicts the most possible interactions
occurring between the target proteins.
Elimination of crystal packing interfaces and interactions
After we obtained the interfaces of the proteins in our network
using PRISM, non-biological interfaces, if any, should be
eliminated. Interfaces having a biological score greater than
60% according to the NOXclass [57] outputs were accepted as
biologically relevant. Thus, 357 interaction interfaces were
predicted and most of them (80%) had biological scores greater
than 80%. Also, including the known interfaces coming from 3D
structures, the resulting network which includes interface infor-
mation is called ‘iSPIN’. It consists of 534 proteins and 563
interactions. The subnetwork of cancer-related interactions
(ciSPIN) includes 381 proteins and 375 interactions. The protein
and interaction numbers are given in Table 5.
Hub classification: Single-interface and multi-interface
hubs
Kim et al. (2006) [19] classified protein hubs as singlish-interface
and multi-interface hubs. The former has at most two distinct
binding interfaces, whereas the latter has more than two binding
interfaces. In this study, we also classified the hubs in iSPIN
according to the number of distinct binding interfaces; we defined
single-interface hubs as protein hubs with only one distinct binding
interface and multi-interface hubs as those with more than one
distinct binding interface. To distinguish overlapping interfaces
from non-overlapping interfaces, we looked at the shared residue
percentage of the interfaces of hub proteins. We defined shared
residue percentage as the ratio of number of shared residues to the
number of total interface residues. If the interface residues are
shared at a percentage greater than 20%, then the corresponding
interface is an overlapping one and interactions occurring through
this interface are mutually exclusive. On the other hand, if the
interface is not shared at all, meaning that the shared residue
percentage is less than 20%, then this is a non-overlapping
interface and the interaction through this interface is simulta-
neously possible, independent of each other.
Interface property analysis
For interface analysis, we used PROTORP [29] which invokes
NACCESS [70], SURFNET [74] and PRINCIP (SURFNET)
[74] for interface accessible surface area and gap volume and
planarity calculation, respectively. PROTORP calculates the
amino acid composition of residues defined in the interface as a
percentage value of those classified as polar, non-polar and
charged as described previously by Jones and Thornton [75]. The
amino acid compositions were weighted and then normalized by
the interface ASA values which were calculated using NACCESS.
Statistical tests
Mann-Whitney test (also called Wilcoxon rank sum), which is a
nonparametric test that compares the distributions of two
unmatched groups, was performed to compare cancer and non-
cancer related interface properties. Two-tailed p values were
calculated at a=0.05.
Classification analysis
To check whether the differences in cancer & noncancer related
interface properties are significant in practice or not, Weka [39],
Structural Cancer Protein Interaction Network
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contained equal number of cancer-related (positive set) and
noncancer interfaces (negative set). To equalize the number of
data in the positive and negative set, a Weka filter called
‘‘Resample’’ which creates a stratified subsample of the given
dataset, was used. ‘‘Resample’’ filter ensures that overall class
distributions are retained within the sample. 10 runs of 10-fold
cross validation were performed using four different classifier
algorithms; decision stump, naı ¨ve bayes, support vector machine
(SVM) and adaboostm1. Decision stump is a machine learning
algorithm consisting of a single-level Decision Tree. It is mostly
used as a component in boosting algorithms such as Adaboostm1.
In Weka, Adaboostm1 functions as a meta-classifier which uses
decision stump by weighting several iterations of it. Naı ¨ve Bayes is
a simple probabilistic classifier whereas SVM is a supervised
learning classifier. The statistical measures of the tests are
Accuracy and Precision. Accuracy is the percentage of correctly
classified instances calculated by TP+TN/(TP+TN+FN+FP). For
cancer class predictions, TP is the number of correctly predicted
cancer interfaces and FP is the number of non-cancer interfaces
which are predicted as cancer-related. TN is the number of
correctly predicted noncancer interfaces and FN is the number of
cancer-related interfaces which are predicted as being non-cancer.
Precision is the proportion of the instances which are correctly
predicted among all predictions and calculated by TP/(TP+FP) for
cancer class. For noncancer class, precision is calculated by TN/
(TN+FN). Average of two precision values (for cancer and
noncancer) comes out to be Precision of the tests.
Interaction energy calculation
For the case studies, interaction energies were calculated using
FoldX [53,54]. Firstly, the complex structures were subjected to an
optimization procedure using the repair function of FoldX. During
this step, all side chains were moved slightly to eliminate small van
der Waals’ clashes. Next, AnalyzeComplex function was used to
determine the interaction energy between the proteins. Through-
out the FoldX calculations, the default parameters were used.
Network topology analysis
All the parameters describing the network topology were
calculated using NetworkAnalyzer, which is a Java plugin for
Cytoscape [76]. Another Cytoscape plugin MCODE [44], which
detects densely connected regions in protein-protein interaction
networks based on a vertex weighting method by local
neighborhood density, was used to find highly connected
subnetworks in the network. BINGO [77], being also a Cytoscape
plugin, determines which Gene Ontology terms are significantly
overrepresented in subgraphs of biological networks.
Supporting Information
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